TEDUGLUTIDE

TEDUGLUTIDE was reported 13437 times

TEDUGLUTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 93 0.6414
1 GASTROINTESTINAL STOMA OUTPUT DECREASED 80 0.5674
2 STOMA SITE DERMATITIS 18 0.5455
3 GASTROINTESTINAL STOMA OUTPUT INCREASED 213 0.4542
4 STOMA SITE COMPLICATION 7 0.3889
5 STOMA COMPLICATION 382 0.3760
6 STOMA PROLAPSE 53 0.3706
7 VASCULAR DEVICE INFECTION 1178 0.2594
8 STOMA SITE OEDEMA 55 0.2511
9 URINE OUTPUT FLUCTUATION 8 0.2500
10 STOMA OBSTRUCTION 46 0.2009
11 ECTOPIC GASTRIC MUCOSA 6 0.2000
12 OBSTRUCTIVE DEFAECATION 13 0.1940
13 DUODENAL POLYP 40 0.1887
14 SMALL INTESTINE POLYP 13 0.1585
15 VITAMIN A DEFICIENCY 15 0.1471
16 CATHETER SITE GRANULOMA 8 0.1404
17 DEVICE RELATED BACTERAEMIA 43 0.1387
18 OVERGROWTH BACTERIAL 34 0.1264
19 DEVICE RELATED SEPSIS 249 0.1236
20 GASTROINTESTINAL STOMA COMPLICATION 188 0.1195
21 ANORECTAL POLYP 11 0.1028
22 GASTROINTESTINAL MICROORGANISM OVERGROWTH 34 0.0966
23 PUNCTURE SITE ERYTHEMA 8 0.0930
24 FAECAL VOLUME INCREASED 48 0.0923
25 SHORT-BOWEL SYNDROME 60 0.0922
26 FAECAL VOLUME DECREASED 41 0.0854
27 PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE 7 0.0787
28 STOMA SITE HAEMORRHAGE 118 0.0766
29 STOMA SITE DISCOMFORT 16 0.0705
30 DUMPING SYNDROME 18 0.0684
31 STOMAL HERNIA 23 0.0627
32 BODY HEIGHT INCREASED 30 0.0612
33 GASTROSTOMY TUBE SITE COMPLICATION 12 0.0600
34 ENTEROCUTANEOUS FISTULA 52 0.0590
35 STOMA SITE PAIN 83 0.0565
36 STOMA SITE INFLAMMATION 42 0.0562
37 CATHETER SITE THROMBOSIS 14 0.0511
38 OBSTRUCTION 200 0.0500
39 VASCULAR DEVICE OCCLUSION 16 0.0472
40 ABDOMINAL WALL WOUND 7 0.0455
41 VITAMIN A DECREASED 7 0.0452
42 GASTROINTESTINAL BACTERIAL OVERGROWTH 27 0.0450
43 GASTROENTERITIS ADENOVIRUS 7 0.0446
44 DEVICE RELATED THROMBOSIS 40 0.0406
45 GASTROINTESTINAL TRACT ADENOMA 14 0.0384
46 INTESTINAL MUCOSAL HYPERTROPHY 7 0.0383
47 COLORECTAL ADENOMA 12 0.0372
48 STOMA SITE ABSCESS 9 0.0370
49 BLOOD MAGNESIUM ABNORMAL 20 0.0361
50 PARENTERAL NUTRITION 8 0.0346
51 DEATH OF RELATIVE 14 0.0345
52 MAGNESIUM DEFICIENCY 16 0.0341
53 CATHETER SITE INFLAMMATION 19 0.0337
54 DEVICE RELATED INFECTION 516 0.0335
55 GASTRIC MUCOSAL HYPERTROPHY 8 0.0324
56 URINE OUTPUT INCREASED 79 0.0302
57 BACTERIAL TRANSLOCATION 9 0.0284
58 SPINAL CORD INFECTION 18 0.0277
59 GASTROINTESTINAL FISTULA 23 0.0263
60 STOMA CLOSURE 8 0.0257
61 FAECES HARD 100 0.0257
62 ABNORMAL FAECES 201 0.0245
63 INTESTINAL PROLAPSE 10 0.0239
64 STOMA SITE IRRITATION 13 0.0239
65 PRODUCT RECONSTITUTION QUALITY ISSUE 21 0.0235
66 STOMA SITE EXTRAVASATION 9 0.0233
67 ROTAVIRUS INFECTION 13 0.0226
68 HAEMATOLOGICAL INFECTION 55 0.0225
69 PROTEIN DEFICIENCY 7 0.0224
70 FEEDING INTOLERANCE 10 0.0222
71 ANASTOMOTIC ULCER 10 0.0217
72 FLUID IMBALANCE 15 0.0213
73 ILEOSTOMY CLOSURE 7 0.0209
74 GASTROINTESTINAL POLYP 7 0.0208
75 FISTULA DISCHARGE 26 0.0206
76 DIALYSIS RELATED COMPLICATION 7 0.0198
77 MEDICAL DEVICE SITE INFECTION 12 0.0193
78 FEEDING TUBE USER 7 0.0191
79 HYPERVOLAEMIA 91 0.0184
80 INTESTINAL PSEUDO-OBSTRUCTION 16 0.0182
81 GASTRIC POLYPS 40 0.0177
82 WEIGHT FLUCTUATION 178 0.0170
83 ANAL STENOSIS 9 0.0169
84 INFECTED FISTULA 9 0.0168
85 PRODUCT DISTRIBUTION ISSUE 155 0.0167
86 INSURANCE ISSUE 254 0.0166
87 STOMA SITE REACTION 11 0.0161
88 INTESTINAL DILATATION 21 0.0157
89 INTESTINAL ANASTOMOSIS 10 0.0155
90 STOMA SITE INFECTION 20 0.0154
91 HERNIA PAIN 7 0.0153
92 GALLBLADDER RUPTURE 7 0.0151
93 FAECAL VOMITING 8 0.0150
94 FISTULA OF SMALL INTESTINE 6 0.0144
95 NUTRITIONAL CONDITION ABNORMAL 10 0.0143
96 BLOOD MAGNESIUM DECREASED 121 0.0140
97 CATHETER SITE INFECTION 53 0.0140
98 STOMA SITE DISCHARGE 38 0.0139
99 NOROVIRUS INFECTION 20 0.0139
100 HYPOVITAMINOSIS 18 0.0136
101 CATHETER SITE DISCHARGE 15 0.0133
102 VESTIBULAR NEURONITIS 7 0.0131
103 APPETITE DISORDER 84 0.0127
104 UNDERWEIGHT 24 0.0122
105 MALNUTRITION 133 0.0119
106 CAMPYLOBACTER GASTROENTERITIS 7 0.0118
107 COMPLICATION ASSOCIATED WITH DEVICE 169 0.0116
108 GASTROINTESTINAL OBSTRUCTION 28 0.0116
109 KLEBSIELLA BACTERAEMIA 11 0.0116
110 SUBILEUS 24 0.0115
111 URETEROLITHIASIS 12 0.0114
112 BLOOD ELECTROLYTES DECREASED 16 0.0113
113 CANDIDA SEPSIS 10 0.0111
114 GALLBLADDER ENLARGEMENT 12 0.0111
115 FISTULA 125 0.0111
116 INTESTINAL OBSTRUCTION 419 0.0111
117 GASTROINTESTINAL SCARRING 8 0.0110
118 PANCREATIC CYST 21 0.0110
119 SMALL INTESTINAL OBSTRUCTION 135 0.0110
120 INTESTINAL POLYP 18 0.0109
121 INFREQUENT BOWEL MOVEMENTS 27 0.0108
122 ABDOMINAL WALL ABSCESS 7 0.0108
123 STOMA SITE ERYTHEMA 20 0.0107
124 RHINOVIRUS INFECTION 41 0.0105
125 MALABSORPTION 55 0.0105
126 INTUSSUSCEPTION 10 0.0105
127 WEIGHT ABNORMAL 25 0.0104
128 PANCREATIC ENZYMES INCREASED 15 0.0102
129 BILIARY DILATATION 15 0.0102
130 INCISIONAL HERNIA 14 0.0101
131 BOWEL MOVEMENT IRREGULARITY 77 0.0100
132 GASTROINTESTINAL WALL THICKENING 15 0.0100
133 BLOOD MAGNESIUM INCREASED 9 0.0100
134 ABDOMINAL ABSCESS 44 0.0099
135 INTESTINAL FISTULA 14 0.0099
136 EXCESSIVE GRANULATION TISSUE 8 0.0099
137 LARGE INTESTINE POLYP 68 0.0098
138 CATHETER SITE SWELLING 9 0.0096
139 INTERVERTEBRAL DISCITIS 18 0.0095
140 CHOLECYSTITIS INFECTIVE 26 0.0094
141 IRON DEFICIENCY 42 0.0093
142 ADENOMA BENIGN 8 0.0093
143 BILIARY OBSTRUCTION 12 0.0093
144 BILE DUCT STONE 29 0.0091
145 POLYP 59 0.0090
146 JUGULAR VEIN THROMBOSIS 16 0.0090
147 CATHETER SITE ERYTHEMA 19 0.0089
148 PRODUCT CLOSURE REMOVAL DIFFICULT 9 0.0088
149 ELECTROLYTE IMBALANCE 100 0.0086
150 URINE OUTPUT DECREASED 75 0.0086
151 SMALL INTESTINAL STENOSIS 9 0.0085
152 RECTAL PROLAPSE 10 0.0083
153 BACTERAEMIA 97 0.0082
154 RECTAL POLYP 8 0.0081
155 RENAL COLIC 18 0.0080
156 GASTROINTESTINAL OEDEMA 14 0.0079
157 PANCREATIC DISORDER 39 0.0079
158 ABDOMINAL HERNIA 36 0.0079
159 BLOOD POTASSIUM ABNORMAL 21 0.0079
160 INABILITY TO AFFORD MEDICATION 78 0.0078
161 GASTROINTESTINAL VIRAL INFECTION 8 0.0077
162 FEBRILE INFECTION 9 0.0076
163 FUNGAEMIA 12 0.0076
164 BILE DUCT STENOSIS 9 0.0075
165 CALCULUS BLADDER 10 0.0073
166 CATHETER SITE PAIN 19 0.0073
167 PRODUCT AVAILABILITY ISSUE 165 0.0072
168 CAMPYLOBACTER INFECTION 6 0.0072
169 GASTRIC DILATATION 12 0.0072
170 CALCULUS URINARY 11 0.0071
171 FLATULENCE 405 0.0071
172 STAPHYLOCOCCAL BACTERAEMIA 31 0.0071
173 AMYLASE INCREASED 26 0.0070
174 SUBCLAVIAN VEIN THROMBOSIS 8 0.0070
175 HYPERPHAGIA 28 0.0070
176 GASTROINTESTINAL BACTERIAL INFECTION 8 0.0070
177 ABDOMINAL ADHESIONS 22 0.0070
178 ABDOMINAL DISTENSION 726 0.0069
179 LIPASE INCREASED 53 0.0069
180 GASTROINTESTINAL SOUNDS ABNORMAL 34 0.0069
181 BLOOD IRON DECREASED 81 0.0068
182 VOLVULUS 16 0.0067
183 CENTRAL VENOUS CATHETERISATION 20 0.0066
184 ADHESION 10 0.0066
185 FREQUENT BOWEL MOVEMENTS 179 0.0066
186 VITAMIN B12 DECREASED 19 0.0066
187 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
188 DEHYDRATION 876 0.0066
189 NEEDLE ISSUE 189 0.0065
190 DYSCHEZIA 19 0.0062
191 KLEBSIELLA SEPSIS 7 0.0062
192 ACROCHORDON 8 0.0060
193 RESPIRATORY TRACT INFECTION VIRAL 14 0.0060
194 ENDOCARDITIS 30 0.0058
195 LARGE INTESTINAL OBSTRUCTION 13 0.0058
196 GASTROINTESTINAL MOTILITY DISORDER 31 0.0058
197 SYSTEMIC CANDIDA 14 0.0056
198 BLOOD CREATININE ABNORMAL 19 0.0055
199 VENA CAVA THROMBOSIS 9 0.0054
200 PRODUCT CONTAINER ISSUE 46 0.0054
201 HERNIA 102 0.0053
202 STAPHYLOCOCCAL SEPSIS 26 0.0053
203 MUCOUS STOOLS 26 0.0052
204 GASTROINTESTINAL INFECTION 47 0.0052
205 INTESTINAL STENOSIS 22 0.0052
206 ADMINISTRATION SITE PAIN 6 0.0052
207 CHOLECYSTITIS 62 0.0052
208 SYRINGE ISSUE 90 0.0051
209 INTESTINAL MASS 7 0.0051
210 NEPHROLITHIASIS 234 0.0051
211 ILEUS 63 0.0051
212 PHYSICAL DECONDITIONING 13 0.0050
213 DYSPLASIA 6 0.0050
214 NEUROENDOCRINE TUMOUR 7 0.0049
215 FOOD INTOLERANCE 18 0.0049
216 PNEUMONIA KLEBSIELLA 9 0.0049
217 BLOOD ELECTROLYTES ABNORMAL 6 0.0049
218 CHOLECYSTITIS ACUTE 27 0.0048
219 ENTEROBACTER INFECTION 8 0.0048
220 GASTROINTESTINAL PAIN 52 0.0047
221 GASTROINTESTINAL INFLAMMATION 37 0.0047
222 DISCOURAGEMENT 11 0.0047
223 SEPSIS 524 0.0047
224 FAECES SOFT 34 0.0047
225 RECTAL DISCHARGE 17 0.0046
226 ABDOMINAL PAIN 1070 0.0046
227 BLOOD POTASSIUM DECREASED 138 0.0046
228 INJECTION SITE SCAR 13 0.0046
229 FAECALOMA 25 0.0046
230 VITAMIN D DECREASED 39 0.0046
231 INCREASED APPETITE 87 0.0045
232 WEIGHT DECREASED 1267 0.0045
233 RENAL FUNCTION TEST ABNORMAL 21 0.0045
234 ENTEROCOLITIS 26 0.0045
235 ADENOVIRUS INFECTION 13 0.0045
236 POST PROCEDURAL COMPLICATION 86 0.0045
237 BILIARY COLIC 13 0.0045
238 INTESTINAL OPERATION 7 0.0044
239 INTESTINAL ULCER 7 0.0044
240 BLOOD PHOSPHORUS DECREASED 16 0.0044
241 ABDOMINAL INFECTION 11 0.0043
242 BLOOD CREATINE INCREASED 19 0.0043
243 GALLBLADDER DISORDER 76 0.0043
244 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37 0.0042
245 PORTAL HYPERTENSION 13 0.0042
246 PNEUMATOSIS INTESTINALIS 12 0.0042
247 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 16 0.0042
248 BLOOD ALBUMIN DECREASED 33 0.0042
249 EARLY SATIETY 8 0.0041
250 MULTIPLE ALLERGIES 32 0.0041
251 COLOSTOMY 8 0.0041
252 PROCTALGIA 26 0.0040
253 HYPOMAGNESAEMIA 56 0.0040
254 ANORECTAL DISORDER 8 0.0040
255 BLOOD CULTURE POSITIVE 12 0.0040
256 VITAMIN D DEFICIENCY 39 0.0040
257 VERTIGO POSITIONAL 7 0.0040
258 INTESTINAL ISCHAEMIA 22 0.0040
259 CHOLELITHIASIS 130 0.0040
260 PANCREATIC FAILURE 7 0.0040
261 KLEBSIELLA INFECTION 20 0.0040
262 VITAMIN B12 DEFICIENCY 16 0.0039
263 WEIGHT INCREASED 882 0.0039
264 GASTROENTERITIS VIRAL 71 0.0039
265 LUMBAR VERTEBRAL FRACTURE 18 0.0039
266 FLUID OVERLOAD 57 0.0039
267 GASTROENTERITIS 57 0.0039
268 ARTHRITIS INFECTIVE 18 0.0039
269 OESOPHAGEAL STENOSIS 11 0.0039
270 EATING DISORDER 82 0.0038
271 HOSPITALISATION 590 0.0038
272 VENOUS THROMBOSIS 15 0.0038
273 PROSTATOMEGALY 15 0.0038
274 PANCREATITIS CHRONIC 9 0.0038
275 STAPHYLOCOCCAL INFECTION 125 0.0038
276 CATHETER PLACEMENT 7 0.0038
277 DEVICE OCCLUSION 53 0.0038
278 PRODUCT LEAKAGE 21 0.0037
279 DEFAECATION URGENCY 26 0.0037
280 ABDOMINAL RIGIDITY 10 0.0037
281 PRODUCT DOSE OMISSION ISSUE 1074 0.0036
282 DUODENITIS 11 0.0036
283 ENTERITIS INFECTIOUS 6 0.0035
284 LARGE INTESTINAL STENOSIS 7 0.0035
285 FEEDING DISORDER 70 0.0034
286 HICCUPS 28 0.0034
287 FLUID RETENTION 172 0.0034
288 BACTERIAL INFECTION 62 0.0033
289 VARICES OESOPHAGEAL 10 0.0033
290 LIQUID PRODUCT PHYSICAL ISSUE 24 0.0033
291 BLOOD CALCIUM DECREASED 37 0.0033
292 SKIN PAPILLOMA 13 0.0032
293 INFUSION SITE BRUISING 7 0.0032
294 RENAL PAIN 34 0.0032
295 RESPIRATORY RATE DECREASED 10 0.0032
296 BLOOD BICARBONATE DECREASED 6 0.0032
297 HUNGER 44 0.0032
298 GASTRIC INFECTION 12 0.0031
299 PRODUCT DOSE OMISSION IN ERROR 87 0.0031
300 BACTERIAL SEPSIS 10 0.0031
301 INCORRECT DOSAGE ADMINISTERED 15 0.0031
302 KIDNEY INFECTION 60 0.0031
303 PRODUCT PREPARATION ISSUE 20 0.0030
304 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 546 0.0030
305 ABDOMINAL MASS 8 0.0030
306 COMPRESSION FRACTURE 16 0.0030
307 SKIN ABRASION 14 0.0030
308 PRODUCT SUPPLY ISSUE 21 0.0029
309 BLOOD PHOSPHORUS INCREASED 8 0.0029
310 OSTEOMYELITIS 53 0.0029
311 IRON DEFICIENCY ANAEMIA 27 0.0029
312 CHANGE OF BOWEL HABIT 6 0.0029
313 ESCHERICHIA INFECTION 24 0.0029
314 POOR VENOUS ACCESS 30 0.0029
315 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
316 ACIDOSIS 22 0.0029
317 BLOOD CREATININE DECREASED 9 0.0029
318 INVESTIGATION 9 0.0029
319 AORTIC STENOSIS 10 0.0029
320 ANAL HAEMORRHAGE 8 0.0029
321 DEVICE CONNECTION ISSUE 6 0.0028
322 RENAL DISORDER 132 0.0028
323 HYPOALBUMINAEMIA 22 0.0028
324 ABDOMINAL TENDERNESS 14 0.0028
325 NOCTURIA 34 0.0028
326 VIRAL INFECTION 92 0.0028
327 ILEOSTOMY 7 0.0027
328 COLONOSCOPY 6 0.0027
329 FRUSTRATION TOLERANCE DECREASED 22 0.0027
330 THERAPY INTERRUPTED 192 0.0027
331 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
332 ATYPICAL PNEUMONIA 8 0.0027
333 CHRONIC GASTRITIS 6 0.0027
334 PROTEIN TOTAL DECREASED 10 0.0027
335 INJECTION SITE MASS 98 0.0026
336 FAECES DISCOLOURED 57 0.0026
337 ANAL FISSURE 14 0.0026
338 PRODUCT USE ISSUE 490 0.0026
339 PRODUCT USE COMPLAINT 41 0.0026
340 GRANULOMA 9 0.0026
341 BLOOD POTASSIUM INCREASED 42 0.0026
342 ABSCESS LIMB 11 0.0026
343 PERIPHERAL SWELLING 397 0.0026
344 HYDRONEPHROSIS 19 0.0025
345 HYPOKALAEMIA 117 0.0025
346 ILLNESS 261 0.0025
347 BREAST MASS 17 0.0025
348 PRODUCT PRESCRIBING ERROR 60 0.0025
349 INTESTINAL PERFORATION 28 0.0025
350 THIRST 44 0.0025
351 INFUSION SITE HAEMORRHAGE 8 0.0024
352 ERUCTATION 47 0.0024
353 PYELONEPHRITIS 21 0.0024
354 URINE ABNORMALITY 11 0.0024
355 ANAL ABSCESS 13 0.0024
356 ABDOMINAL PAIN UPPER 496 0.0024
357 HEPATIC ENZYME ABNORMAL 12 0.0024
358 CATHETER SITE HAEMORRHAGE 6 0.0024
359 UROSEPSIS 22 0.0024
360 INJECTION SITE BRUISING 190 0.0024
361 HAEMATOCHEZIA 130 0.0024
362 IMPAIRED GASTRIC EMPTYING 32 0.0023
363 URINE ANALYSIS ABNORMAL 7 0.0023
364 SCAR 40 0.0023
365 RENAL IMPAIRMENT 195 0.0023
366 HYPOPHAGIA 59 0.0023
367 MASTICATION DISORDER 7 0.0023
368 DECREASED APPETITE 531 0.0023
369 FOOD POISONING 12 0.0022
370 URINARY TRACT INFECTION 381 0.0022
371 COVID-19 391 0.0022
372 HYPOVOLAEMIA 13 0.0022
373 INFLAMMATORY MARKER INCREASED 11 0.0022
374 BODY TEMPERATURE INCREASED 45 0.0022
375 HEPATIC STEATOSIS 41 0.0022
376 FLUID INTAKE REDUCED 11 0.0022
377 GASTROINTESTINAL DISORDER 196 0.0022
378 ENTERITIS 14 0.0022
379 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
380 THROMBOSIS IN DEVICE 7 0.0021
381 SUSPECTED COVID-19 7 0.0021
382 ANAL INCONTINENCE 19 0.0021
383 POST PROCEDURAL INFECTION 17 0.0021
384 CLAVICLE FRACTURE 8 0.0021
385 ESCHERICHIA SEPSIS 6 0.0021
386 INFECTION 299 0.0021
387 MELANOCYTIC NAEVUS 9 0.0021
388 LIVER FUNCTION TEST INCREASED 44 0.0020
389 INJECTION SITE DISCHARGE 11 0.0020
390 PROCEDURAL HAEMORRHAGE 8 0.0020
391 HEPATIC FIBROSIS 7 0.0020
392 ENERGY INCREASED 12 0.0020
393 PHARYNGITIS STREPTOCOCCAL 22 0.0020
394 HYPOPHOSPHATAEMIA 15 0.0020
395 HAEMOGLOBIN ABNORMAL 13 0.0020
396 MICTURITION DISORDER 7 0.0020
397 BLOOD SODIUM DECREASED 38 0.0020
398 WOUND INFECTION 22 0.0020
399 PRODUCT PACKAGING ISSUE 19 0.0020
400 PRODUCT SOLUBILITY ABNORMAL 10 0.0020
401 BRAIN FOG 31 0.0020
402 PANCREATITIS 104 0.0020
403 FEAR OF INJECTION 14 0.0020
404 DRUG EFFECT LESS THAN EXPECTED 29 0.0020
405 FAILURE TO THRIVE 10 0.0019
406 GASTROINTESTINAL PERFORATION 8 0.0019
407 WRIST FRACTURE 23 0.0019
408 BREAST CANCER RECURRENT 6 0.0019
409 ANORECTAL DISCOMFORT 10 0.0019
410 ABSCESS 30 0.0019
411 MUSCLE SPASMS 345 0.0019
412 ANAL FISTULA 10 0.0019
413 OEDEMA 101 0.0019
414 CHROMATURIA 42 0.0019
415 AORTIC ANEURYSM 14 0.0018
416 INFLUENZA 205 0.0018
417 PULMONARY THROMBOSIS 20 0.0018
418 PYREXIA 632 0.0018
419 THROMBOSIS 146 0.0018
420 VOMITING 852 0.0018
421 CYSTITIS 57 0.0018
422 RETCHING 38 0.0018
423 ABDOMINAL PAIN LOWER 45 0.0018
424 POLLAKIURIA 74 0.0018
425 CHOLANGITIS 11 0.0018
426 ULCER HAEMORRHAGE 12 0.0018
427 FUNGAL INFECTION 59 0.0018
428 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
429 OEDEMA PERIPHERAL 214 0.0018
430 DISEASE COMPLICATION 8 0.0017
431 PRODUCT PRESCRIBING ISSUE 38 0.0017
432 ERYTHEMA NODOSUM 6 0.0017
433 FLANK PAIN 16 0.0017
434 GENERALISED OEDEMA 21 0.0017
435 PROCEDURAL COMPLICATION 13 0.0017
436 FOOD ALLERGY 13 0.0017
437 HIP FRACTURE 54 0.0017
438 HYPOVOLAEMIC SHOCK 8 0.0017
439 CHOLECYSTECTOMY 19 0.0017
440 BLOOD PRESSURE ABNORMAL 33 0.0017
441 DIARRHOEA 1061 0.0016
442 LACTIC ACIDOSIS 53 0.0016
443 PRODUCT DISPENSING ISSUE 7 0.0016
444 DEVICE BREAKAGE 66 0.0016
445 ABDOMINAL DISCOMFORT 272 0.0016
446 ARTHROPOD BITE 12 0.0016
447 HEART RATE ABNORMAL 9 0.0016
448 TREATMENT NONCOMPLIANCE 88 0.0016
449 RECTAL HAEMORRHAGE 69 0.0016
450 OVARIAN CYST 16 0.0016
451 POLYURIA 13 0.0016
452 DERMATITIS CONTACT 18 0.0016
453 HYPERTHERMIA 12 0.0016
454 ILEUS PARALYTIC 7 0.0016
455 NIGHT SWEATS 50 0.0016
456 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
457 SKIN WARM 9 0.0015
458 HIATUS HERNIA 20 0.0015
459 HAEMORRHOIDS 30 0.0015
460 INFLAMMATORY BOWEL DISEASE 15 0.0015
461 METABOLIC ACIDOSIS 49 0.0015
462 TOOTH INFECTION 20 0.0015
463 LIGAMENT SPRAIN 15 0.0015
464 PROCEDURAL PAIN 42 0.0015
465 LOCALISED OEDEMA 7 0.0015
466 CORONAVIRUS INFECTION 10 0.0015
467 BLOOD TEST ABNORMAL 21 0.0015
468 COLITIS ISCHAEMIC 10 0.0015
469 CANDIDA INFECTION 25 0.0015
470 CONSTIPATION 322 0.0015
471 HYPERSOMNIA 42 0.0015
472 ARTHRITIS BACTERIAL 6 0.0015
473 SUBCUTANEOUS ABSCESS 7 0.0015
474 HYPERKALAEMIA 51 0.0015
475 HUMERUS FRACTURE 7 0.0015
476 ENTEROCOCCAL INFECTION 7 0.0014
477 RENAL FAILURE 190 0.0014
478 HYPOCALCAEMIA 27 0.0014
479 SEPTIC SHOCK 62 0.0014
480 PANCREATITIS ACUTE 32 0.0014
481 INFUSION SITE ERYTHEMA 12 0.0014
482 COLECTOMY 8 0.0014
483 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
484 NAUSEA 1106 0.0014
485 ERYSIPELAS 7 0.0014
486 MUSCLE STRAIN 12 0.0014
487 PNEUMONIA 449 0.0014
488 SCIATICA 22 0.0014
489 BACK INJURY 15 0.0014
490 SWELLING 129 0.0014
491 BLOOD URINE PRESENT 26 0.0014
492 GASTRITIS 36 0.0014
493 FEMORAL NECK FRACTURE 7 0.0014
494 UPPER LIMB FRACTURE 27 0.0014
495 COVID-19 PNEUMONIA 16 0.0014
496 HYPERBILIRUBINAEMIA 14 0.0014
497 POOR QUALITY SLEEP 29 0.0013
498 BLOOD PRESSURE DECREASED 89 0.0013
499 BLOOD CREATININE INCREASED 87 0.0013
500 INJECTION SITE DISCOMFORT 14 0.0013
501 LIMB INJURY 36 0.0013
502 HEPATOMEGALY 13 0.0013
503 INGUINAL HERNIA 8 0.0013
504 INTERNAL HAEMORRHAGE 15 0.0013
505 RIB FRACTURE 27 0.0013
506 DEVICE DISLOCATION 57 0.0013
507 DEVICE LEAKAGE 56 0.0013
508 POST PROCEDURAL HAEMORRHAGE 15 0.0013
509 GOUT 23 0.0013
510 RENAL CYST 10 0.0013
511 STREPTOCOCCAL INFECTION 7 0.0013
512 LOWER LIMB FRACTURE 24 0.0012
513 ACUTE KIDNEY INJURY 191 0.0012
514 GASTROINTESTINAL HAEMORRHAGE 104 0.0012
515 LOCALISED INFECTION 30 0.0012
516 PERIORBITAL SWELLING 7 0.0012
517 NASOPHARYNGITIS 228 0.0012
518 INCONTINENCE 13 0.0012
519 INJECTION SITE ERYTHEMA 152 0.0012
520 JOINT SWELLING 147 0.0012
521 MASS 17 0.0012
522 ANEURYSM 6 0.0012
523 SECRETION DISCHARGE 15 0.0012
524 SPLENOMEGALY 14 0.0012
525 ULCER 19 0.0012
526 OSTEOPOROSIS 49 0.0012
527 CELLULITIS 60 0.0012
528 INCORRECT DOSE ADMINISTERED 271 0.0012
529 POSTOPERATIVE WOUND INFECTION 8 0.0012
530 INJECTION SITE IRRITATION 15 0.0012
531 SURGERY 69 0.0012
532 AMMONIA INCREASED 6 0.0012
533 SQUAMOUS CELL CARCINOMA 11 0.0012
534 LEUKAEMIA 11 0.0012
535 ONYCHOCLASIS 8 0.0012
536 COLITIS 44 0.0012
537 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
538 INJECTION SITE VESICLES 7 0.0012
539 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
540 INFLUENZA LIKE ILLNESS 93 0.0011
541 GASTRIC HAEMORRHAGE 13 0.0011
542 JOINT INJURY 24 0.0011
543 BEHAVIOUR DISORDER 6 0.0011
544 WOUND 31 0.0011
545 APATHY 16 0.0011
546 NEOPLASM MALIGNANT 73 0.0011
547 AUTISM SPECTRUM DISORDER 6 0.0011
548 BASAL CELL CARCINOMA 17 0.0011
549 HAEMATOMA 28 0.0011
550 PULMONARY MASS 16 0.0011
551 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
552 PALLOR 29 0.0011
553 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
554 SKIN MASS 7 0.0010
555 POST-TRAUMATIC STRESS DISORDER 7 0.0010
556 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
557 HEPATIC ENZYME INCREASED 71 0.0010
558 INJECTION SITE DISCOLOURATION 13 0.0010
559 LIVER DISORDER 46 0.0010
560 RESPIRATORY TRACT INFECTION 27 0.0010
561 PLEURAL EFFUSION 63 0.0010
562 DRUG DOSE OMISSION 171 0.0010
563 PRODUCT LABEL ISSUE 7 0.0010
564 PELVIC FRACTURE 8 0.0010
565 MUSCLE ATROPHY 13 0.0010
566 PRODUCT PREPARATION ERROR 21 0.0010
567 SKIN CANCER 22 0.0010
568 COAGULOPATHY 17 0.0010
569 FACE OEDEMA 17 0.0010
570 LARGE INTESTINE PERFORATION 7 0.0010
571 INJECTION SITE INDURATION 13 0.0010
572 TRANSPLANT REJECTION 8 0.0010
573 SPINAL FRACTURE 20 0.0010
574 RHINITIS 8 0.0010
575 LETHARGY 57 0.0010
576 SEASONAL ALLERGY 14 0.0010
577 TASTE DISORDER 20 0.0010
578 TOOTH ABSCESS 10 0.0010
579 THYROID DISORDER 15 0.0010
580 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 69 0.0010
581 RESPIRATORY DISORDER 29 0.0010
582 BACK PAIN 225 0.0010
583 SPINAL COMPRESSION FRACTURE 8 0.0010
584 DYSPEPSIA 95 0.0010
585 BLOOD UREA INCREASED 16 0.0010
586 DYSURIA 35 0.0009
587 PRODUCT ADMINISTRATION ERROR 19 0.0009
588 MALAISE 412 0.0009
589 CHOLESTASIS 18 0.0009
590 INJURY ASSOCIATED WITH DEVICE 19 0.0009
591 PSEUDOMONAS INFECTION 8 0.0009
592 ANAEMIA 176 0.0009
593 FALL 306 0.0009
594 HEAD INJURY 29 0.0009
595 DIALYSIS 13 0.0009
596 THERAPY CESSATION 47 0.0009
597 CONTUSION 88 0.0009
598 DEVICE MALFUNCTION 64 0.0009
599 NO ADVERSE EVENT 165 0.0009
600 CHRONIC KIDNEY DISEASE 69 0.0009
601 HAEMATEMESIS 23 0.0009
602 SWELLING FACE 59 0.0009
603 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
604 DEATH 778 0.0009
605 URINARY RETENTION 30 0.0009
606 CHOLECYSTITIS CHRONIC 6 0.0009
607 MALIGNANT MELANOMA 12 0.0009
608 HEPATIC FAILURE 27 0.0009
609 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
610 HYPERCALCAEMIA 11 0.0009
611 PHARYNGITIS 11 0.0009
612 MITRAL VALVE INCOMPETENCE 10 0.0009
613 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
614 GINGIVAL PAIN 7 0.0009
615 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
616 BLOOD DISORDER 7 0.0009
617 COLON CANCER 13 0.0009
618 CHILLS 102 0.0009
619 HYPOGLYCAEMIA 42 0.0009
620 DEVICE DEFECTIVE 15 0.0009
621 DEEP VEIN THROMBOSIS 56 0.0009
622 SHOCK HAEMORRHAGIC 7 0.0009
623 DEVICE USE ISSUE 15 0.0009
624 INJECTION SITE URTICARIA 21 0.0009
625 DIARRHOEA HAEMORRHAGIC 8 0.0009
626 INFUSION SITE PAIN 11 0.0009
627 SPINAL PAIN 10 0.0009
628 HEPATIC CIRRHOSIS 16 0.0009
629 RHINORRHOEA 55 0.0009
630 CARDIAC FAILURE 68 0.0008
631 ASTHENIA 318 0.0008
632 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
633 FOOT FRACTURE 16 0.0008
634 LIMB DISCOMFORT 26 0.0008
635 ANKLE FRACTURE 13 0.0008
636 HAEMOGLOBIN DECREASED 86 0.0008
637 BEDRIDDEN 11 0.0008
638 ROAD TRAFFIC ACCIDENT 35 0.0008
639 EAR INFECTION 22 0.0008
640 SLEEP DISORDER 58 0.0008
641 ASPIRATION 9 0.0008
642 INJECTION SITE NODULE 9 0.0008
643 TOOTH FRACTURE 9 0.0008
644 ANURIA 7 0.0008
645 BODY TEMPERATURE DECREASED 8 0.0008
646 CARDIOMYOPATHY 12 0.0008
647 HOT FLUSH 61 0.0008
648 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
649 HYPERHIDROSIS 104 0.0008
650 CYST 10 0.0008
651 PNEUMONIA ASPIRATION 20 0.0008
652 CRYING 29 0.0008
653 PRODUCT PHYSICAL ISSUE 16 0.0008
654 VAGINAL DISCHARGE 8 0.0008
655 RESPIRATORY RATE INCREASED 7 0.0008
656 SEIZURE 91 0.0008
657 BRONCHITIS 58 0.0008
658 NEOPLASM 9 0.0008
659 UNINTENTIONAL MEDICAL DEVICE REMOVAL 9 0.0008
660 CONCUSSION 6 0.0008
661 ILL-DEFINED DISORDER 47 0.0008
662 HERPES ZOSTER 44 0.0008
663 TOOTH DISORDER 17 0.0008
664 HYPONATRAEMIA 43 0.0008
665 PNEUMONIA BACTERIAL 7 0.0008
666 HYPERTHYROIDISM 11 0.0008
667 BLOOD PRESSURE INCREASED 116 0.0008
668 NERVE COMPRESSION 7 0.0008
669 DEPRESSED MOOD 40 0.0008
670 MUSCULOSKELETAL DISCOMFORT 13 0.0008
671 MACULAR DEGENERATION 9 0.0008
672 HEPATIC ENCEPHALOPATHY 7 0.0007
673 ASCITES 22 0.0007
674 GAIT INABILITY 25 0.0007
675 ARTERIOSCLEROSIS 7 0.0007
676 GENERAL PHYSICAL HEALTH DETERIORATION 86 0.0007
677 C-REACTIVE PROTEIN INCREASED 27 0.0007
678 UNEVALUABLE EVENT 56 0.0007
679 DECUBITUS ULCER 6 0.0007
680 SKIN LACERATION 8 0.0007
681 PERICARDIAL EFFUSION 17 0.0007
682 INJECTION SITE SWELLING 56 0.0007
683 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
684 LEUKOCYTOSIS 13 0.0007
685 SKIN INFECTION 8 0.0007
686 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
687 HOSPICE CARE 7 0.0007
688 INJECTION SITE PAIN 217 0.0007
689 SINUS DISORDER 14 0.0007
690 INJECTION SITE HAEMORRHAGE 56 0.0007
691 CYANOSIS 11 0.0007
692 BRAIN INJURY 7 0.0007
693 INJECTION SITE REACTION 48 0.0007
694 SLUGGISHNESS 7 0.0007
695 INJECTION SITE RASH 21 0.0007
696 BLOOD CALCIUM INCREASED 6 0.0007
697 COLD SWEAT 12 0.0007
698 SYNCOPE 68 0.0007
699 INFLAMMATION 35 0.0007
700 FEMUR FRACTURE 21 0.0007
701 DISCOMFORT 41 0.0007
702 ACCIDENT 8 0.0007
703 HAEMORRHAGE 70 0.0007
704 CARDIAC DISORDER 62 0.0007
705 JOINT DISLOCATION 7 0.0007
706 BURSITIS 8 0.0007
707 NEURALGIA 16 0.0007
708 END STAGE RENAL DISEASE 12 0.0007
709 DEVICE ISSUE 59 0.0007
710 DEVICE FAILURE 10 0.0007
711 HAEMATOCRIT DECREASED 13 0.0007
712 MUSCULOSKELETAL CHEST PAIN 10 0.0006
713 APHONIA 9 0.0006
714 MENTAL DISORDER 28 0.0006
715 HAEMATURIA 22 0.0006
716 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
717 MIGRAINE 61 0.0006
718 ARTHRITIS 50 0.0006
719 LUNG DISORDER 31 0.0006
720 SLEEP APNOEA SYNDROME 12 0.0006
721 OROPHARYNGEAL PAIN 58 0.0006
722 BLOOD GLUCOSE DECREASED 30 0.0006
723 ACUTE RESPIRATORY FAILURE 12 0.0006
724 GLAUCOMA 12 0.0006
725 ROTATOR CUFF SYNDROME 8 0.0006
726 EPILEPSY 19 0.0006
727 EYE INFECTION 7 0.0006
728 PAIN 379 0.0006
729 HEART RATE INCREASED 61 0.0006
730 MICTURITION URGENCY 7 0.0006
731 SKIN DISCOLOURATION 28 0.0006
732 FEELING ABNORMAL 145 0.0006
733 RESTLESS LEGS SYNDROME 11 0.0006
734 BLADDER DISORDER 6 0.0006
735 COUGH 169 0.0006
736 EYELID OEDEMA 7 0.0006
737 BLOOD GLUCOSE ABNORMAL 11 0.0006
738 FATIGUE 463 0.0006
739 PAIN IN EXTREMITY 175 0.0006
740 MELAENA 13 0.0006
741 CIRCULATORY COLLAPSE 10 0.0006
742 LUNG NEOPLASM MALIGNANT 24 0.0006
743 HEADACHE 366 0.0006
744 PULMONARY OEDEMA 26 0.0006
745 LOSS OF CONSCIOUSNESS 74 0.0006
746 ADRENAL INSUFFICIENCY 7 0.0006
747 LOCAL SWELLING 10 0.0006
748 BLINDNESS UNILATERAL 8 0.0006
749 CARDIAC FAILURE CONGESTIVE 45 0.0006
750 INSOMNIA 149 0.0006
751 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 29 0.0006
752 HEPATIC CYTOLYSIS 7 0.0005
753 LYMPHADENOPATHY 19 0.0005
754 PULMONARY EMBOLISM 51 0.0005
755 MOOD SWINGS 17 0.0005
756 ORAL CANDIDIASIS 7 0.0005
757 BONE PAIN 31 0.0005
758 NECK PAIN 29 0.0005
759 LYMPHOMA 8 0.0005
760 SINUSITIS 53 0.0005
761 NERVOUSNESS 27 0.0005
762 ORAL HERPES 10 0.0005
763 ACUTE HEPATIC FAILURE 7 0.0005
764 EXPIRED PRODUCT ADMINISTERED 17 0.0005
765 SKIN LESION 14 0.0005
766 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
767 PNEUMOTHORAX 8 0.0005
768 ORAL DISCOMFORT 7 0.0005
769 PRODUCT STORAGE ERROR 44 0.0005
770 HYPOTHYROIDISM 16 0.0005
771 PREGNANCY 10 0.0005
772 SKIN REACTION 7 0.0005
773 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
774 BRONCHOSPASM 7 0.0005
775 HEPATIC FUNCTION ABNORMAL 18 0.0005
776 DYSPNOEA 273 0.0005
777 SKIN DISORDER 16 0.0005
778 ADVERSE DRUG REACTION 43 0.0005
779 CEREBROVASCULAR ACCIDENT 81 0.0005
780 PERICARDITIS 8 0.0005
781 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
782 GASTRIC ULCER 9 0.0005
783 TACHYCARDIA 42 0.0005
784 FEELING COLD 13 0.0005
785 ARTHRALGIA 194 0.0005
786 GASTRIC DISORDER 16 0.0005
787 ARRHYTHMIA 22 0.0005
788 CHEST PAIN 86 0.0005
789 ATRIAL FIBRILLATION 45 0.0005
790 VERTIGO 28 0.0005
791 MOBILITY DECREASED 33 0.0005
792 HEPATIC CANCER 11 0.0005
793 FEELING HOT 28 0.0005
794 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
795 DYSMENORRHOEA 6 0.0005
796 HEAD DISCOMFORT 8 0.0005
797 DYSPNOEA EXERTIONAL 17 0.0005
798 PANCREATIC CARCINOMA 13 0.0004
799 EXTRA DOSE ADMINISTERED 18 0.0004
800 BLOOD BILIRUBIN INCREASED 12 0.0004
801 TOOTHACHE 8 0.0004
802 PELVIC PAIN 8 0.0004
803 BALANCE DISORDER 38 0.0004
804 CATARACT 26 0.0004
805 MENTAL STATUS CHANGES 12 0.0004
806 DYSPHAGIA 41 0.0004
807 DEPRESSION 98 0.0004
808 HAEMOPTYSIS 12 0.0004
809 IMPAIRED HEALING 14 0.0004
810 INTENTIONAL DOSE OMISSION 12 0.0004
811 CEREBRAL HAEMORRHAGE 15 0.0004
812 HYPOTENSION 84 0.0004
813 INJECTION SITE PRURITUS 28 0.0004
814 PRODUCT DOSE OMISSION 27 0.0004
815 EAR PAIN 8 0.0004
816 RESPIRATORY FAILURE 30 0.0004
817 UNDERDOSE 30 0.0004
818 DYSPHONIA 24 0.0004
819 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
820 DEVICE DIFFICULT TO USE 27 0.0004
821 LABORATORY TEST ABNORMAL 12 0.0004
822 TRANSAMINASES INCREASED 9 0.0004
823 ORTHOSTATIC HYPOTENSION 7 0.0004
824 METASTASES TO LIVER 7 0.0004
825 FULL BLOOD COUNT DECREASED 8 0.0004
826 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 80 0.0004
827 VAGINAL HAEMORRHAGE 17 0.0004
828 ERECTILE DYSFUNCTION 10 0.0004
829 PRODUCT USE IN UNAPPROVED INDICATION 96 0.0004
830 BREAST CANCER 36 0.0004
831 EJECTION FRACTION DECREASED 6 0.0004
832 RED BLOOD CELL COUNT DECREASED 11 0.0004
833 HYPERGLYCAEMIA 14 0.0004
834 PULMONARY HYPERTENSION 8 0.0004
835 ACCIDENTAL OVERDOSE 14 0.0004
836 DEAFNESS 10 0.0004
837 MEMORY IMPAIRMENT 52 0.0004
838 NEUROPATHY PERIPHERAL 36 0.0004
839 LIVER FUNCTION TEST ABNORMAL 11 0.0004
840 MIDDLE INSOMNIA 7 0.0004
841 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
842 SOMNOLENCE 75 0.0004
843 DIZZINESS 185 0.0004
844 FRACTURE 7 0.0004
845 PRODUCT DISPENSING ERROR 8 0.0004
846 THROMBOCYTOPENIA 41 0.0004
847 CARDIAC ARREST 30 0.0004
848 STOMATITIS 22 0.0004
849 TREMOR 60 0.0004
850 MEDICATION ERROR 20 0.0004
851 ADVERSE EVENT 33 0.0004
852 DEMENTIA 10 0.0004
853 PANIC ATTACK 13 0.0004
854 ANXIETY 101 0.0004
855 AMNESIA 23 0.0004
856 DRUG INTOLERANCE 34 0.0004
857 ANGINA PECTORIS 10 0.0003
858 SPEECH DISORDER 18 0.0003
859 RASH MACULAR 12 0.0003
860 NASAL CONGESTION 20 0.0003
861 PERITONITIS 7 0.0003
862 TOOTH LOSS 7 0.0003
863 URINARY INCONTINENCE 10 0.0003
864 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
865 GAIT DISTURBANCE 64 0.0003
866 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
867 DRY MOUTH 27 0.0003
868 MOOD ALTERED 9 0.0003
869 ABNORMAL BEHAVIOUR 13 0.0003
870 IRRITABLE BOWEL SYNDROME 7 0.0003
871 RESPIRATORY DISTRESS 9 0.0003
872 CONJUNCTIVITIS 6 0.0003
873 EYE SWELLING 12 0.0003
874 DRUG INEFFECTIVE 425 0.0003
875 MYOCARDIAL INFARCTION 56 0.0003
876 AGEUSIA 8 0.0003
877 RASH PAPULAR 7 0.0003
878 SNEEZING 7 0.0003
879 THERAPY NON-RESPONDER 14 0.0003
880 CARDIO-RESPIRATORY ARREST 13 0.0003
881 DYSSTASIA 9 0.0003
882 CHOKING 6 0.0003
883 ARTHROPATHY 17 0.0003
884 BLADDER CANCER 18 0.0003
885 MUSCULOSKELETAL PAIN 16 0.0003
886 JOINT STIFFNESS 8 0.0003
887 DISABILITY 6 0.0003
888 RENAL INJURY 9 0.0003
889 DIABETES MELLITUS 23 0.0003
890 RESTLESSNESS 11 0.0003
891 LEUKOPENIA 15 0.0003
892 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 14 0.0003
893 CONDITION AGGRAVATED 91 0.0003
894 APHASIA 9 0.0003
895 FEAR 8 0.0003
896 JAUNDICE 8 0.0003
897 COMA 14 0.0003
898 HYPOAESTHESIA 44 0.0003
899 PRODUCTIVE COUGH 14 0.0003
900 DIVERTICULITIS 8 0.0003
901 NERVOUS SYSTEM DISORDER 9 0.0003
902 PRESYNCOPE 7 0.0003
903 DERMATITIS 6 0.0003
904 HEART RATE DECREASED 10 0.0003
905 OXYGEN SATURATION DECREASED 16 0.0003
906 ASTHMA 32 0.0003
907 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
908 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
909 HYPERTENSION 59 0.0003
910 EYE DISORDER 9 0.0003
911 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
912 DIPLOPIA 7 0.0003
913 ECZEMA 14 0.0003
914 BLISTER 15 0.0003
915 CONFUSIONAL STATE 43 0.0003
916 PALPITATIONS 31 0.0003
917 CHEST DISCOMFORT 27 0.0003
918 DISTURBANCE IN ATTENTION 14 0.0003
919 RASH PRURITIC 14 0.0003
920 ERYTHEMA 53 0.0003
921 PRODUCT QUALITY ISSUE 35 0.0003
922 RHEUMATOID ARTHRITIS 29 0.0003
923 MYALGIA 43 0.0003
924 COLORECTAL CANCER 12 0.0003
925 RASH 109 0.0002
926 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
927 ALOPECIA 48 0.0002
928 ENCEPHALOPATHY 6 0.0002
929 SKIN IRRITATION 11 0.0002
930 TINNITUS 11 0.0002
931 MUSCULAR WEAKNESS 27 0.0002
932 OFF LABEL USE 208 0.0002
933 IRRITABILITY 14 0.0002
934 DISORIENTATION 9 0.0002
935 VISION BLURRED 31 0.0002
936 PRURITUS 85 0.0002
937 MUSCULOSKELETAL STIFFNESS 19 0.0002
938 BURNING SENSATION 15 0.0002
939 OSTEOARTHRITIS 9 0.0002
940 HYPERSENSITIVITY 39 0.0002
941 VISUAL IMPAIRMENT 26 0.0002
942 INTENTIONAL PRODUCT MISUSE 18 0.0002
943 PARAESTHESIA 32 0.0002
944 URTICARIA 34 0.0002
945 DRY SKIN 27 0.0002
946 EPISTAXIS 15 0.0002
947 HYPOXIA 7 0.0002
948 PLATELET COUNT DECREASED 21 0.0002
949 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
950 EYE PAIN 11 0.0002
951 EMOTIONAL DISORDER 6 0.0002
952 DYSARTHRIA 7 0.0002
953 HYPOACUSIS 8 0.0002
954 INFUSION RELATED REACTION 12 0.0002
955 ANGER 6 0.0002
956 DELIRIUM 6 0.0002
957 PSORIATIC ARTHROPATHY 7 0.0002
958 BLINDNESS 7 0.0002
959 BLOOD CHOLESTEROL INCREASED 8 0.0002
960 DISEASE RECURRENCE 8 0.0002
961 FLUSHING 17 0.0002
962 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
963 PROSTATE CANCER 13 0.0002
964 ACNE 12 0.0002
965 ANGIOEDEMA 7 0.0002
966 OVERDOSE 34 0.0002
967 COLITIS ULCERATIVE 7 0.0002
968 COGNITIVE DISORDER 7 0.0001
969 ABORTION SPONTANEOUS 6 0.0001
970 RENAL CANCER 7 0.0001
971 ANAPHYLACTIC REACTION 8 0.0001
972 PANCYTOPENIA 8 0.0001
973 HALLUCINATION 10 0.0001
974 BLOOD GLUCOSE INCREASED 25 0.0001
975 BRADYCARDIA 7 0.0001
976 SUICIDAL IDEATION 12 0.0001
977 SKIN EXFOLIATION 11 0.0001
978 EXPOSURE DURING PREGNANCY 8 0.0001
979 INJURY 9 0.0001
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
981 DYSGEUSIA 9 0.0001
982 NEUTROPENIA 16 0.0001
983 AGITATION 8 0.0001
984 DRUG INTERACTION 16 0.0001
985 EMOTIONAL DISTRESS 12 0.0001
986 TREATMENT FAILURE 8 0.0001
987 PSORIASIS 10 0.0001
988 DISEASE PROGRESSION 9 0.0001
989 DRUG WITHDRAWAL SYNDROME 6 0.0001
990 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
991 TOXICITY TO VARIOUS AGENTS 7 0.0000